Medical Necessity and Qualitative Drug Screening: A Survey of Payer Coverage Determination and Medical Policies

This plenary session is a precursor to the breakout sessions by region over the next several days. This program presents a general overview of changes to federal and state laws and rules, as well as agency program activities, that will impact pain management practitioners nationwide. Also addressed will be top line information such as the FDA/REMS Blueprint. The main focus will be on the Prescription Drug Monitoring Programs (PDMPs) nationwide, the pain clinic laws cropping up in various states, and critical changes to licensing board rules impacting pain management.

Related Content